Table 1

Demographic and baseline characteristics of patients and HCPs
Characteristic
N 775
Male, % 37
Median age, year (SD) 44.6 (15.1)
National patient organization member, % 10
Single, no partner 25
Single, with partner 26
Married 49
Full-time 43
Part-time 16
Chronic back pain 15
Migraine 14
Arthritis 13
Depression 12
Asthma 10
In flare 11
Mildly symptomatic 43
In remission 46
Currently receiving UC therapy, % 76
5-ASA/aminosalicylate 75
Monotherapy 43
Corticosteroids 32
Immune therapy 24
Antibiotics 8
Biological therapy 15
Other 9
Physicians
N 475
Male, % 82
Mean qualification year (SD) 1992 (9.1)
Gastroenterology 82
Internal medicine 18
Lower GI/IBD specialist, % 68
Office 19
Hospital 64
Equal 17
City center 71
Suburban 23
Rural 6
Teaching hospital, % 67
Public 89
Private 11
Mean % of working day devoted to clinical practice (SD) 87.4 (11.2)
Mean number of patients with UC seen in typical month, n (SD) 35.2 (33.0)
N 50
Male, % 8
Mean year of qualification (SD) 1992 (7.5)
Mean year becoming IBD Nurse (SD) 2003 (3.8)
Nurse practitioner 10
Nurse prescriber 6
Clinical nurse specialist 84
City center 56
Suburban 40
Rural 4
Teaching hospital, % 80
Mean % of working day devoted to direct patient care (SD) 80.8 (14.1)
Mean number of patients with UC seen in typical month, n (SD) 66.6 (40.2)
Percentage of nurses who make treatment decisions for patients with UC 86
Percentage of nurses who are qualified nurse prescriber 44
Percentage of nurses who write 5-ASA prescriptions for mild-to-moderate UC 77
Mean number of 5-ASA prescriptions written per month (SD) 21.4 (15.9)

HCP, healthcare professional; SD, standard deviation; UC, ulcerative colitis; 5-ASA, 5-aminosalicylic acid; GI, gastrointestinal; IBD, inflammatory bowel disease.

*All patients currently taking prescription medication for their UC.

Immunomodulator or immunosuppressant.

Schreiber et al.

Schreiber et al. BMC Gastroenterology 2012 12:108   doi:10.1186/1471-230X-12-108

Open Data